Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Today’s market could make Sysco stock break out, will it?: https://www.marketbeat.com/logos/articles/med_20240127132727_todays-market-could-make-sysco-stock-break-out-wil.jpg
Today’s market could make Sysco stock break out, will it?

The new market cycle is getting underway, and some investors – maybe even yourself – are getting carried away by the bullish media and the market’s all-time high prices today. Far from sounding

Industrial's building a base for upward momentum: https://www.marketbeat.com/logos/articles/med_20240128123916_industrials-building-a-base-for-upward-momentum.jpg
Industrial's building a base for upward momentum

The overall market continues to trade at all-time highs, with the SPDR S&P 500 ETF Trust (NYSE: SPY) already up an impressive 2.5% year-to-date and over 16% during the previous three months. The

Hess stock to see 96% growth in EPS: https://www.marketbeat.com/logos/articles/med_20240128122213_hess-stock-to-see-96-growth-in-eps.jpg
Hess stock to see 96% growth in EPS

The markets may have just ended their super cycle for the past four years (2020-2024), sponsored by low-interest rate environments pushed by the FED to counteract the effects of the COVID-19

Could Rumble’s video platform reach its tipping point in 2024?: https://www.marketbeat.com/logos/articles/med_20240128161713_chart-rum.jpg
Could Rumble’s video platform reach its tipping point in 2024?

Video-sharing platform Rumble Inc. (NASDAQ: RUM) shares surged over 60% in a week, driven by several catalysts. Perhaps more importantly, it's caught the attention of traders and investors.

2 undisputed chip leaders that each owns a 90% market share: https://www.marketbeat.com/logos/articles/med_20240128163640_charty-nvda.jpg
2 undisputed chip leaders that each owns a 90% market share

Commanding 80% or more market share in any industry segment is a worthy feat, especially on a global scale in the computer and technology sector. They say the lion on top of the mountain is not as

Marriott International is the juggernaut that keeps growing: https://www.marketbeat.com/logos/articles/med_20240128161359_chart-mar2.jpg
Marriott International is the juggernaut that keeps growing

Leading global hospitality giant Marriott International Inc. (NASDAQ: MAR) stock continues to make new all-time highs as the travel boom continues to rebound. Unlike most industries facing

SoFi stock to have huge earnings growth, markets like the story: https://www.marketbeat.com/logos/articles/med_20240128175136_sofi-stock-to-have-huge-earnings-growth-markets-li.jpg
SoFi stock to have huge earnings growth, markets like the story

Many market participants have become weary of the new all-time highs being pushed out by the market indices, such as the broader S&P 500 or the technology-heavy NASDAQ. The law of the market stood

What makes Textron a must-own aerospace stock for 2024?: https://www.marketbeat.com/logos/articles/med_20240126092917_what-makes-textron-a-must-own-aerospace-stock-for.jpg
What makes Textron a must-own aerospace stock for 2024?

A 9% jump during Wednesday's session made Textron Inc. (NYSE: TXT) one of the best-performing equities on the market. This latest jump in share price for the Rhode Island-based aerospace company

Is Nike consolidating before a fresh rally?: https://www.marketbeat.com/logos/articles/med_20240126092539_is-nike-consolidating-before-a-fresh-rally.jpg
Is Nike consolidating before a fresh rally?

For a stock that could do nothing wrong for a long time, it's been a tough couple of months for Nike Inc. (NYSE: NKE). A dodgy earnings report last month, including the dreaded weak forward

3 well-known consumer cyclical stocks offering 5% dividends: https://www.marketbeat.com/logos/articles/med_20240126063644_3-well-known-consumer-cyclical-stocks-offering-5-d.jpg
3 well-known consumer cyclical stocks offering 5% dividends

Lately, the major domestic stock indices are getting into a habit of setting fresh all-time highs.

Unwavering hopes of aggressive Federal Reserve interest rate cuts in 2024 have pushed the Dow

3 large caps near 52-week lows with large dividends: https://www.marketbeat.com/logos/articles/med_20240126063229_3-large-caps-near-52-week-lows-with-large-dividend.jpg
3 large caps near 52-week lows with large dividends

How fitting that Thursday night’s full moon was also referred to as the ‘wolf moon.’ 

U.S. stock indices howled to fresh all-time highs this week as the first full moon of 2024 lit up the evening

Abbott Laboratories on track for new highs in 2024: https://www.marketbeat.com/logos/articles/med_20240125084342_chart-abt-1252024ver001.png
Abbott Laboratories on track for new highs in 2024

Abbott Laboratories (NYSE: ABT) share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report that was largely as expected, with

This one wireless service stock could blow past earnings: https://www.marketbeat.com/logos/articles/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg
This one wireless service stock could blow past earnings

Now that the Federal Reserve (the Fed) has pivoted its strategy to the opposite end of where it had been throughout 2023, meaning they are now proposing to cut interest rates after an aggressive

These 5 growth stocks are now in buy ranges: https://www.marketbeat.com/logos/articles/med_20240125065914_these-5-growth-stocks-are-now-in-buy-ranges.jpg
These 5 growth stocks are now in buy ranges

Chart patterns and consolidations are worth watching, as they provide actionable guidance for making a purchase. 

With the recent uptrend in large-cap stocks, as reflected by the performance of

Verizon and AT&T: One is a high-yield value, the other a trap: https://www.marketbeat.com/logos/articles/med_20240124114037_chart-vz-att-1242023ver001.png
Verizon and AT&T: One is a high-yield value, the other a trap

Verizon Communications Inc. (NYSE: VZ) and AT&T Inc. (NYSE: T) have presented value and yield to investors for years. 

However, they failed to sustain interest in their stocks, creating a drag on

Food fight! Which grocery store stocks will win in 2024?: https://www.marketbeat.com/logos/articles/med_20240124122319_food-fight-which-grocery-store-stocks-will-win-in.jpg
Food fight! Which grocery store stocks will win in 2024?

Food distributors and retailers are living up to their reputation as the best consumer staples industry to own. 

Up 2.1% year-to-date, the group has a sizable early lead over its roughly flat sec

5 top healthcare stocks for earnings growth in 2024: https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg
5 top healthcare stocks for earnings growth in 2024

While the healthcare sector delivered lackluster profit growth in 2023, it should change this year. 

Sector components forecast to show the biggest earnings year-over-year earnings improvement

Why Apple’s about to smash through $200 and continue: https://www.marketbeat.com/logos/articles/med_20240124111807_why-apples-about-to-smash-through-200-and-continue.jpg
Why Apple’s about to smash through $200 and continue

Microsoft Corporation (NASDAQ: MSFT) recently overtook Apple Inc. (NASDAQ: AAPL) as the world's most valuable company while also setting its all-time high; expectations are high for Apple to make

Will leverage and pricing power drive Netflix to a record high?: https://www.marketbeat.com/logos/articles/med_20240124071952_chart-nflx-1242024ver001.png
Will leverage and pricing power drive Netflix to a record high?

The Netflix Inc. (NASDAQ: NFLX) narrative is not without risk. The company struggled with growth following the COVID-19 bubble, but those days are behind. The story today is leverage, driven by

Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal.  Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73356/Aktiencheck240124_01.001.png
Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal. Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Großinvestoren begeistert von innovativer Krebstherapie. Neuer 199% Biotech Aktientip nach 15.973% mit BioNTech

 

24.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

3 reasons to buy Meta stock ahead of earnings: https://www.marketbeat.com/logos/articles/med_20240123084749_3-reasons-to-buy-meta-ahead-of-earnings.jpg
3 reasons to buy Meta stock ahead of earnings

Meta Inc (NASDAQ: META) reports Thursday of next week in what will be one of the more closely watched reports of the year so far. The tech giant ended 2023 on a high, and its rally has, for the